SBC Medical Group Holdings Incorporated Common Stock
SBC
SBC Medical Group Holdings Inc is a management company that provides management services to cosmetic treatment centers mainly in Japan. It is focused on providing comprehensive management services to franchisee clinics, including but not limited to advertising and marketing needs across various platforms (such as social media networks), staff management (such as recruitment and training), booking reservations for franchisee clinic customers, assistance with franchisee employee housing rentals and facility rentals, construction and design of franchisee clinics, medical equipment and medical consumables procurement (resale). The firm generates revenue mostly from these management services.
Last trade$6.17
Day change-$0.01 (-0.16%)
Day range$5.77 – $6.27
Volume462,920
Market cap$634M
OpenXNAS
Fundamentals
Key company ratios and reported financial statements.
Source: Massive.com
Key ratios
Valuation
Market capitalization
$633.93M
Price / earnings
12.93×
Price / book
2.4×
Price / sales
3.62×
EV / sales
2.78×
EV / EBITDA
7.1×
Profitability
Earnings per share
$0.48
Return on assets
12.06%
Return on equity
18.58%
Dividend yield
0%
Liquidity and leverage
Debt / equity
0.14×
Current ratio
3.31×
Quick ratio
3.27×
Cash ratio
2.35×
Cash flow
Price / cash flow
10.09×
Price / free cash flow
10.44×
Free cash flow
$60.7M
Ratios use trailing-twelve-month financials and market data as of
Nov 16, 2026.
Financial statements
Income and cash flow amounts are for the period; balance sheets are point-in-time
snapshots. Amounts are shown in USD. Latest 8 quarterly or 5 annual periods are
displayed when available.
Income statement for SBC, quarterly periods
Line item
Q2 FY2026 Jun 30, 2026
Q1 FY2026 Mar 31, 2026
Q4 FY2025 Dec 31, 2025
Q3 FY2025 Sep 30, 2025
Q2 FY2025 Jun 30, 2025
Q1 FY2025 Mar 31, 2025
Q4 FY2024 Dec 31, 2024
Q3 FY2024 Sep 30, 2024
Revenue
$49.19M
$43.06M
$39.57M
$43.35M
$43.36M
$47.33M
$44.42M
$53.08M
Cost of revenue
$13.21M
$12.71M
$10.64M
$12.74M
$13.35M
$9.6M
$10.55M
$9.85M
Gross profit
$35.98M
$30.35M
$28.93M
$30.61M
$30.01M
$37.73M
$33.87M
$43.24M
Selling, general and administrative
$17.02M
$12.63M
$16.08M
$14.73M
$15.46M
$13.53M
$14.1M
$29.4M
Research and development
$0
$0
$0
$0
$0
$0
$0
$0
Total operating expenses
$17.02M
$12.63M
$16.08M
$14.73M
$15.46M
$13.53M
$29.15M
$29.4M
Operating income
$18.96M
$17.72M
$12.85M
$15.88M
$14.55M
$24.2M
$4.72M
$13.83M
Interest expense
-$128.63K
-$114.81K
-$56.09K
-$48.64K
-$49.65K
-$6.21K
-$12.4K
-$5.47K
Income before taxes
$19.55M
$18.86M
$18.57M
$18.51M
$13.54M
$31.45M
$6.06M
$13.11M
Income taxes
$7.82M
$7.53M
$4.29M
$5.67M
$11.1M
$9.96M
-$488.55K
$10.27M
Net income
$11.16M
$11.33M
$14.28M
$12.83M
$2.44M
$21.49M
$6.55M
$2.83M
Net income attributable to common shareholders
$10.69M
$11.31M
$14.2M
$12.82M
$2.46M
$21.5M
$6.54M
$2.83M
EBITDA
$20.09M
$18.39M
$13.52M
$16.63M
$15.19M
$24.83M
$20.71M
$14.85M
Basic earnings per share
$0.10
$0.11
$0.14
$0.12
$0.02
$0.21
$0.06
$0.03
Diluted earnings per share
$0.10
$0.11
$0.14
$0.12
$0.02
$0.21
$0.06
$0.03
Recent news
Company coverage with links to the original publishers.
SBC Medical Group's stock surged 37.64% on Friday following strong Q3 earnings with 35% revenue growth to $59 million and announcement of an AI partnership with NeuroBrain Dynamics. The healthcare clinic management company expanded its network by 36 clinics to 293 locations and increased operating income 66% to $26 million with a 45% operating margin. The AI alliance aims to enhance personalized recommendations and streamline operations across the clinic network.
SBC Medical Group Holdings (Nasdaq: SBC) announced that its Director, CFO and COO Yuya Yoshida will present at Cantor Fitzgerald's inaugural Asia Longevity Forum in Hong Kong on October 26-27, 2026, followed by a non-deal roadshow on October 28. The company will showcase its recently established SBC AI Longevity Innovation Inc., which combines clinical data with AI technology to create value in the longevity market.
SBC Medical Group Holdings (Nasdaq: SBC) announced the opening of a new aesthetic dermatology section at BLEZ CLINIC in Bangkok's Asok district through its consulting partnership with BLEZ ASIA Co., Ltd. The section will offer pico laser treatments targeting pigmentation and spot removal, with services launching in June 2026. The expansion targets Japanese expatriates in Thailand and aims to establish a foundation for broader growth across the Thai market and ASEAN region.
SBC Medical Group Holdings Incorporated (Nasdaq: SBC), a Medical Services Organization, announced it will release its Q1 2026 financial results on May 14, 2026, before market open, followed by an earnings conference call at 8:30 a.m. Eastern Time. The company manages a diverse portfolio of clinic brands across multiple healthcare fields and continues expanding its global presence in the United States and Asia.
EmergingGrowth.com announced the schedule for its 88th conference featuring presentations from multiple public companies across various sectors on December 10-11, 2025, providing investors an opportunity to learn about emerging growth companies.
Dividends
Declared distributions and recorded event dates. Forecasts are not
shown.
Updated daily
No declared upcoming dividend found.
Ex-dividend
Amount / share
Pay date
Type
Oct 5, 2005
$0.3225
Nov 1, 2005
recurring
Jul 6, 2005
$0.3225
Aug 1, 2005
recurring
Apr 6, 2005
$0.3225
May 2, 2005
unknown
Jan 6, 2005
$0.3225
Feb 1, 2005
unknown
Oct 6, 2004
$0.3125
Nov 1, 2004
unknown
Stock splits
Historical share-structure events and their execution dates.